Procedures and Therapies News
Sort by: Date | Views
Leading Surgicare Surgeon - Egon Eder - Talks About Revolutionary Breast...
Advances in breast surgery have this year hit an all time high, with the introduction of Macrolane to the UK and with the growing popularity of Transaxillary Incision. Both procedures equal great results without unsightly scars.
Advances in breast surgery have this year hit an all time high, with the introduction of Macrolane to the UK and with the growing popularity of Transaxillary Incision. Both procedures equal great results without unsightly scars.
RMI) Signs AdiStem Distribution Agreement for Thailand ...
AdiStem, a leading provider of autologous, adipose-derived adult stem cell products and procedures has appointed Regenerative Medicine International to distribute their suite of stem cell therapies in Thailand.
AdiStem, a leading provider of autologous, adipose-derived adult stem cell products and procedures has appointed Regenerative Medicine International to distribute their suite of stem cell therapies in Thailand.
There is An Alternative to Going to the Doctor -- Doctors Are Dangerous; a Bold...
PAIA, Hawaii, Sept. 5, 2008 -- In a provocative and controversial new book that is sure to cause a stir in the medical and global community, Dr. D reveals the dangers of modern medicine.
PAIA, Hawaii, Sept. 5, 2008 -- In a provocative and controversial new book that is sure to cause a stir in the medical and global community, Dr. D reveals the dangers of modern medicine.
Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading...
ATTENTION EDITOR, GENERAL DESK
ATTENTION EDITOR, GENERAL DESK
Cancer trials need funds, participants ...
After losing her right leg in 1972 to osteosarcoma, a type of bone cancer, Connie Mielich had years of cancer-free living. ...
After losing her right leg in 1972 to osteosarcoma, a type of bone cancer, Connie Mielich had years of cancer-free living. ...
New Zealand September 4, 2008 AgResearch ...
is urging New Zealanders to make submissions to the Environmental Risk Management Authority (ERMA) regarding its applications currently before the authority.
is urging New Zealanders to make submissions to the Environmental Risk Management Authority (ERMA) regarding its applications currently before the authority.
Editors Memo ...
Does dark matter cause ACL injuries? I see two types of dark matter on our radar. One is quite exciting, at least to this former astronomy major, and one is potentially catastrophic.
Does dark matter cause ACL injuries? I see two types of dark matter on our radar. One is quite exciting, at least to this former astronomy major, and one is potentially catastrophic.
Closings, cancellations ...
BRUNSWICK COUNTYNEW HANOVER COUNTYSchools will be closed Friday.Courts in New Hanover and Pender counties will close at noon Friday.
BRUNSWICK COUNTYNEW HANOVER COUNTYSchools will be closed Friday.Courts in New Hanover and Pender counties will close at noon Friday.
Results Of The APPRAISE-I Dose Guiding Trial ...
While the results of the study did not show a statistically significant difference in ischemic events among any of the four doses of apixaban evaluated, trends emerged that support further study, according to researchers at the Duke Clinical Research Institute. Apixaban targets the activity of Factor Xa, one of several enzymes involved in process of blood coagulation.
While the results of the study did not show a statistically significant difference in ischemic events among any of the four doses of apixaban evaluated, trends emerged that support further study, according to researchers at the Duke Clinical Research Institute. Apixaban targets the activity of Factor Xa, one of several enzymes involved in process of blood coagulation.
Against The Grain: 'Without X-rays, we'd be back in the Dark Ages' ...
Clive Beggs is professor of medical technology at the University of Bradford. He argues that medical engineering's life-saving contribution to healthcare is being largely ignored, and that the discipline is suffering as a result.
Clive Beggs is professor of medical technology at the University of Bradford. He argues that medical engineering's life-saving contribution to healthcare is being largely ignored, and that the discipline is suffering as a result.
Diagnostic tool improves information for physicians ...
LAS CRUCES ? Like Elizabeth Edwards, this year's most famous example, there are thousands of women who have been diagnosed with metastasized breast cancer, who can nonetheless look forward to many years of productive and happy lives.
LAS CRUCES ? Like Elizabeth Edwards, this year's most famous example, there are thousands of women who have been diagnosed with metastasized breast cancer, who can nonetheless look forward to many years of productive and happy lives.
Against The Grain: 'Without X-rays, we'd be back in the Dark Ages' ...
Clive Beggs is professor of medical technology at the University of Bradford. He argues that medical engineering's life-saving contribution to healthcare is being largely ignored, and that the discipline is suffering as a result.
Clive Beggs is professor of medical technology at the University of Bradford. He argues that medical engineering's life-saving contribution to healthcare is being largely ignored, and that the discipline is suffering as a result.
AgResearch encourages Kiwis to have their say ...
AgResearch is urging New Zealanders to make submissions to the Environmental Risk Management Authority (ERMA) regarding its applications currently before the authority.
AgResearch is urging New Zealanders to make submissions to the Environmental Risk Management Authority (ERMA) regarding its applications currently before the authority.
Associated Physicians Group relocates ...
The community celebrated Associated Physicians Group?s (APG) move to the city on Thursday. The group has relocated from its location in Glen Carbon to 1181 South Route 157 in Edwardsville.
The community celebrated Associated Physicians Group?s (APG) move to the city on Thursday. The group has relocated from its location in Glen Carbon to 1181 South Route 157 in Edwardsville.
Protox Completes Enrollment of Phase 2 BPH Trial ...
Vancouver, BC, September 3, 2008--(T-Net)--Protox Therapeutics Inc. (TSX:PRX), a leader in the development of receptor targeted fusion proteins, announced today that it has completed enrollment of patients for its Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia, a common and bothersome urological condition that affects more than 1 million men in Canada and ...
Vancouver, BC, September 3, 2008--(T-Net)--Protox Therapeutics Inc. (TSX:PRX), a leader in the development of receptor targeted fusion proteins, announced today that it has completed enrollment of patients for its Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia, a common and bothersome urological condition that affects more than 1 million men in Canada and ...
TM) in Japan ...
Smith & Nephew, Inc. Orthopaedic Reconstruction & Trauma business and Smith & Nephew Orthopaedics KK Japan today announced that it has received Japanese regulatory C1 Category Reimbursement approval for it's award winning OXINIUM oxidized zirconium technology.
Smith & Nephew, Inc. Orthopaedic Reconstruction & Trauma business and Smith & Nephew Orthopaedics KK Japan today announced that it has received Japanese regulatory C1 Category Reimbursement approval for it's award winning OXINIUM oxidized zirconium technology.
Surgical, Healthcare, Assistive, and Campus Robot Market Strategy, Market...
Research and Markets (http://www.researchandmarkets.com/research/793216/surgical_healthca) has announced the addition of WinterGreen Research, Inc.'s new report "Surgical, Healthcare, Assistive, and Campus Robot Market Strategy, Market Shares, and Market Forecasts, 2008-2014" to their offering.
Research and Markets (http://www.researchandmarkets.com/research/793216/surgical_healthca) has announced the addition of WinterGreen Research, Inc.'s new report "Surgical, Healthcare, Assistive, and Campus Robot Market Strategy, Market Shares, and Market Forecasts, 2008-2014" to their offering.
R) MVP-7 Dental Laser From Millennium Dental Technologies Named 2008 Best...
Millennium Dental Technologies, Inc. today announced that the company's PerioLase® dental laser, the first and only laser designed specifically for use in Laser Assisted New Attachment Procedure(TM) (LANAP(TM)), an FDA-cleared and patented Laser Periodontal Therapy(TM) (LPT(TM)) technique, received nearly perfect ratings from users and an overall rating of 4.5 out of 5 in a recent review ...
Millennium Dental Technologies, Inc. today announced that the company's PerioLase® dental laser, the first and only laser designed specifically for use in Laser Assisted New Attachment Procedure(TM) (LANAP(TM)), an FDA-cleared and patented Laser Periodontal Therapy(TM) (LPT(TM)) technique, received nearly perfect ratings from users and an overall rating of 4.5 out of 5 in a recent review ...
Protox completes enrollment of Phase 2 BPH trial ...
Protox Therapeutics Inc. , a leader in the development of receptor targeted fusion proteins, announced today that it has completed enrollment of patients for its Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia , a common and bothersome urological condition that affects more than 1 million men in Canada and over 50 million men worldwide.
Protox Therapeutics Inc. , a leader in the development of receptor targeted fusion proteins, announced today that it has completed enrollment of patients for its Phase 2 study of PRX302 in males with moderate to severe benign prostatic hyperplasia , a common and bothersome urological condition that affects more than 1 million men in Canada and over 50 million men worldwide.
R) IVUS Technology Used In Imaging Study Of GlaxoSmithKline's Novel...
Volcano Corporation (Nasdaq: VOLC) [ESC Booth # A2-D403], a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, announced the use of its VH(R) IVUS (Virtual Histology IVUS) in GlaxoSmithKline's IBIS-2 trial (Integrated Biomarker and Imaging Study).
Volcano Corporation (Nasdaq: VOLC) [ESC Booth # A2-D403], a leading manufacturer of intravascular ultrasound (IVUS) and functional measurement (FM) technology, announced the use of its VH(R) IVUS (Virtual Histology IVUS) in GlaxoSmithKline's IBIS-2 trial (Integrated Biomarker and Imaging Study).
© 2008 newsero.com 